Include patient voice at every stage of clinical processes: Within3

Drug development teams, even those that speak of incorporating patient voice, often underestimate the potential impact that including that voice can have in the process. They frequently don’t even begin to consider their trial participants until well after the protocol, educational material, and design are underway.

To learn more about how and why trial teams can better incorporate patient voice all along the path, Outsourcing-Pharma spoke with Natalie DiMambro, vice president of product commercialization and training at Within3

OSP: Could you please share your perspective on how the clinical research field’s understanding and prioritization of incorporating patient voice has evolved in recent years?

ND: Historically, the life science industry is known for its commitment to proven methods for collaborating on processes like protocol development. But now, companies are facing shifting expectations, both from consumers and from business partners.

One of the primary forces for change here is the expectation around the patient voice. The bar for patient adherence is high, and if you struggle to engage patients throughout the process, you might find that the trial is not successful or that the resulting product is less likely to be widely effective. 

To increase the likelihood of success, clinical research teams are evolving the old operational model and favoring a more patient-centric approach. In practice, this might mean more patient engagement from early stages, co-design of the trial process, and focusing on things like accessibility and convenience during a study.

Source link

Leave A Reply

Your email address will not be published.